Sectors
INDP
Indaptus Therapeutics, Inc.
1.15
2 x 0.82
2 x 1.42
bid
ask
+
0.01
0.44%
2 @ 04:10 PM
1.15 +0.00 (0.00%)
| Ytd | -60.65% | |
| 1y | -82.38% |
1.09
day range
1.17
0.92
52 week range
8.57
| Open | 1.14 | Prev Close | 1.14 | Low | 1.09 | High | 1.17 | Mkt Cap | 152.56M |
| Vol | 140.26K | Avg Vol | 1.25M | EPS | -3.56 | P/E | N/A | Forward P/E | -0.64 |
| Beta | 1.13 | Short Ratio | 0.54 | Inst. Own | 6.00% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-14 | 50-d Avg | 2.09 | 200-d Avg | 2.23 | 1yr Est | 8.50 |
| Income Statement | |||
| Operating Expenses | 1.81M | ||
| Research and Development Expense | 363.13K | ||
| Selling, General and Administrative Expense | 1.45M | ||
| Operating Income | -1.81M | ||
| Net Income | -1.79M | ||
| Net Income Common Stock | -1.79M | ||
| Net Income Common Stock (USD) | -1.79M | ||
| Consolidated Income | -1.79M | ||
| Earnings per Basic Share | -0.02 | ||
| Earnings per Basic Share (USD) | -0.02 | ||
| Earnings per Diluted Share | -0.02 | ||
| Earning Before Interest & Taxes (EBIT) | -1.79M | ||
| Earning Before Interest & Taxes (USD) | -1.79M | ||
| Weighted Average Shares | 116.13M | ||
| Weighted Average Shares Diluted | 116.13M | ||
| Balance Sheet | |||
| Cash and Equivalents | 7.55M | ||
| Cash and Equivalents (USD) | 7.55M | ||
| Investments | 4.00M | ||
| Investments Current | 4.00M | ||
| Current Assets | 11.99M | ||
| Total Assets | 11.99M | ||
| Current Liabilities | 615.43K | ||
| Total Liabilities | 615.43K | ||
| Accumulated Retained Earnings (Deficit) | -85.62M | ||
| Shareholders Equity | 11.37M | ||
| Shareholders Equity (USD) | 11.37M | ||
| Trade and Non-Trade Payables | 615.43K | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 11.98M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 6.06M | ||
| Issuance (Purchase) of Equity Shares | 12.00M | ||
| Net Cash Flow from Operations | -1.93M | ||
| Share Based Compensation | -64.28K | ||